Rituximab Treatment for Resistant Antiphospholipid Syndrome
ELYSE RUBENSTEIN, DANIEL G. ARKFELD, SAMY METYAS, SHUNTARO SHINADA, SONYA EHRESMANN, and HOWARD A. LIEBMAN
Key Indexing Terms:
From the Division of Rheumatology and Division of Hematology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
E. Rubenstein, MD, Rheumatology Fellow; D.G. Arkfeld, MD, Assistant Professor of Medicine; S. Metyas, MD, Assistant Professor of Medicine; S. Shinada, MD, Rheumatology Fellow; S. Ehresmann, Medical Student, Division of Rheumatology; H.A. Liebman, MD, Associate Professor of Medicine and Pathology, Division of Hematology.
Address reprint requests to Dr. D.G. Arkfeld, Division of Rheumatology, Keck School of Medicine, 2011 Zonal Avenue, HMR 711, Los Angeles, CA 90033. E-mail: firstname.lastname@example.org
Accepted for publication September 26, 2005.